This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
After Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Trevi Therapeutics, Inc. (TRVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
TRVIPositive Net Change
rsi stock-price-movement
Compass Therapeutics, Inc. (CMPX) Loses -28.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Compass Therapeutics, Inc. (CMPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CMPXPositive Net Change
rsi stock-price-movement
Praxis Precision Medicines, Inc. (PRAX) Loses -32.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Praxis Precision Medicines, Inc. (PRAX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PRAXPositive Net Change
rsi stock-price-movement
Down -24.46% in 4 Weeks, Here's Why AnaptysBio, Inc. (ANAB) Looks Ripe for a Turnaround
by Zacks Equity Research
AnaptysBio, Inc. (ANAB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANABPositive Net Change
rsi stock-price-movement
Alector (ALEC) Loses -38.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Alector (ALEC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ALECPositive Net Change
rsi stock-price-movement
Indivior PLC (INDV) Loses -17.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Indivior PLC (INDV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
INDVPositive Net Change
rsi stock-price-movement
Down -17.85% in 4 Weeks, Here's Why You Should You Buy the Dip in Savers Value (SVV)
by Zacks Equity Research
Savers Value (SVV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SVVPositive Net Change
rsi stock-price-movement
Adaptimmune Therapeutics PLC (ADAP) Loses -28.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Adaptimmune Therapeutics PLC (ADAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ADAPNegative Net Change
rsi stock-price-movement
Veeva (VEEV) Loses -23.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Veeva (VEEV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
VEEVNegative Net Change
rsi stock-price-movement
TXO Partners LP (TXO) Loses -7.22% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for TXO Partners LP (TXO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
TXONegative Net Change
rsi stock-price-movement
Janux Therapeutics, Inc. (JANX) Loses -34.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Janux Therapeutics, Inc. (JANX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
JANXPositive Net Change
rsi stock-price-movement
Down -22.86% in 4 Weeks, Here's Why You Should You Buy the Dip in Veeva (VEEV)
by Zacks Equity Research
Veeva (VEEV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
VEEVNegative Net Change
rsi stock-price-movement
Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Eagle Pharmaceuticals (EGRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
rsi stock-price-movement
Down -17.35% in 4 Weeks, Here's Why Riley Exploration Permian, Inc. (REPX) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Riley Exploration Permian, Inc. (REPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
REPXNegative Net Change
rsi stock-price-movement
Down -17.92% in 4 Weeks, Here's Why You Should You Buy the Dip in Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST)
by Zacks Equity Research
Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
VISTPositive Net Change
rsi stock-price-movement
Down -86.57% in 4 Weeks, Here's Why Ventyx Biosciences, Inc. (VTYX) Looks Ripe for a Turnaround
by Zacks Equity Research
Ventyx Biosciences, Inc. (VTYX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
VTYXNegative Net Change
rsi stock-price-movement
Down -5.7% in 4 Weeks, Here's Why APA (APA) Looks Ripe for a Turnaround
by Zacks Equity Research
APA (APA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
APANegative Net Change
rsi stock-price-movement
Down -11.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Penumbra (PEN)
by Zacks Equity Research
Penumbra (PEN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
PENPositive Net Change
rsi stock-price-movement
Here's Why Riley Exploration Permian, Inc. (REPX) is Poised for a Turnaround After Losing -11.54% in 4 Weeks
by Zacks Equity Research
Riley Exploration Permian, Inc. (REPX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
REPXNegative Net Change
rsi stock-price-movement
Oceaneering International (OII) Loses -16.81% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Oceaneering International (OII) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
OIINegative Net Change
rsi stock-price-movement
LSB (LXU) Loses -24.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
LSB (LXU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LXUNegative Net Change
rsi stock-price-movement
After Plunging -11.22% in 4 Weeks, Here's Why the Trend Might Reverse for Berry Petroleum (BRY)
by Zacks Equity Research
Berry Petroleum (BRY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BRYPositive Net Change
rsi stock-price-movement
Down -13.69% in 4 Weeks, Here's Why Amplify Energy (AMPY) Looks Ripe for a Turnaround
by Zacks Equity Research
Amplify Energy (AMPY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
AMPYNegative Net Change
rsi stock-price-movement
After Plunging -7.16% in 4 Weeks, Here's Why the Trend Might Reverse for PBF Energy (PBF)
by Zacks Equity Research
PBF Energy (PBF) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PBFNegative Net Change
rsi stock-price-movement
Down -7.95% in 4 Weeks, Here's Why You Should You Buy the Dip in California Resources Corporation (CRC)
by Zacks Equity Research
California Resources Corporation (CRC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
CRCNegative Net Change
rsi stock-price-movement